CETIRIZINE HYDROCHLORIDE ALLERGY Drug Patent Profile
✉ Email this page to a colleague
When do Cetirizine Hydrochloride Allergy patents expire, and what generic alternatives are available?
Cetirizine Hydrochloride Allergy is a drug marketed by Apotex, Aurobindo Pharma Ltd, Bionpharma, Catalent, Strides Pharma, Sun Pharm Inds Inc, Perrigo R And D, Amneal Pharms Ny, Apotex Inc, Cipla Ltd, Contract Pharmacal, Dr Reddys Labs Ltd, Glenmark Pharms Inc, Granules, Heritage Pharma, Ipca Labs Ltd, Marksans Pharma, Mylan, Orbion Pharms, Pld Acquisitions, Sun Pharm Inds Ltd, Taro, Torrent Pharms Llc, Unichem, and Unique. and is included in twenty-eight NDAs.
The generic ingredient in CETIRIZINE HYDROCHLORIDE ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cetirizine Hydrochloride Allergy
A generic version of CETIRIZINE HYDROCHLORIDE ALLERGY was approved as cetirizine hydrochloride by PADAGIS US on June 17th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CETIRIZINE HYDROCHLORIDE ALLERGY?
- What are the global sales for CETIRIZINE HYDROCHLORIDE ALLERGY?
- What is Average Wholesale Price for CETIRIZINE HYDROCHLORIDE ALLERGY?
Summary for CETIRIZINE HYDROCHLORIDE ALLERGY
| US Patents: | 0 |
| Applicants: | 25 |
| NDAs: | 28 |
| Finished Product Suppliers / Packagers: | 134 |
| Raw Ingredient (Bulk) Api Vendors: | 119 |
| Clinical Trials: | 91 |
| Patent Applications: | 2,616 |
| DailyMed Link: | CETIRIZINE HYDROCHLORIDE ALLERGY at DailyMed |
Recent Clinical Trials for CETIRIZINE HYDROCHLORIDE ALLERGY
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| CURE Drug Repurposing Collaboratory (CDRC) | Phase 3 |
| Emory University | Phase 3 |
| Ruijin Hospital | Phase 1/Phase 2 |
Pharmacology for CETIRIZINE HYDROCHLORIDE ALLERGY
| Drug Class | Histamine-1 Receptor Antagonist |
| Mechanism of Action | Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for CETIRIZINE HYDROCHLORIDE ALLERGY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 077498-001 | Dec 27, 2007 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 076677-002 | Dec 27, 2007 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Unique | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 077829-001 | Aug 26, 2009 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Torrent Pharms Llc | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 079191-001 | Apr 15, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
